U.S. Markets closed

Pfizer acquires Array in 2nd major Boulder bioscience merger this month

Jensen Werley
Pfizer acquires Array in 2nd major Boulder bioscience merger this month

Array BioPharma Inc. (Nasdaq: ARRY) has been acquired by Pfizer Inc. (NYSE: PFE). The Boulder-based biopharmaceutical firm focused on the commercialization of small molecule medicines to treat cancer and other diseases is being acquired for about $11.4 billion, or $48 per share. Upon approval by each company's board and the close of the deal, Array’s employees will join Pfizer and will continue to be located in Boulder.